Method for the inhibition of restenosis associated with coronary

Details Method for the inhibition of restenosis associated with coronary Method for the inhibition of restenosis associated with coronary

1993-09-07

1995-01-31

Henley, III, Raymond J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514930, A61K 3124

Patent

active

053859359

ABSTRACT:
This invention provides a method for treating patients to inhibit restenosis associated with coronary intervention. A 600 mg dosage of Tranilast for a treatment period of three consecutive months after coronary intervention lowers the incidence of restenosis, and reduces the degree of stenosis in patients.

REFERENCES:
patent: 3940422 (1976-02-01), Harita et al.
patent: 4070484 (1978-01-01), Harita et al.
patent: 4337270 (1982-06-01), Noda et al.
Garcia, Mesa, "New approach to the mechanism of antiasthmatic action of Tranilast" Allergol Immunopathol, vol. 18 issue (1). 1990.

Affiliated with

Also associated with

Rating

Method for the inhibition of restenosis associated with coronary does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the inhibition of restenosis associated with coronary, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the inhibition of restenosis associated with coronary will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1102509